Birdwatch Note
2024-02-12 02:34:39 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
この画像内で 岸田総理が行っているのは、デモンストレーションの視察です 健康な人で、実際の状況を再現した実演です 「総理は、宿泊療養等の説明を受けた後、治験概要の説明(治療薬、治験の概要説明及び投薬・健康観察等のデモンストレーション)を受けました」 視察する岸田総理7 首相官邸 https://www.kantei.go.jp/jp/100_kishida/actions/202110/10shisatsu.html 「塩野義製薬の治験デモンストレーションを見守る岸田首相」 首相、飲み薬の治験視察 https://www.sankei.com/article/20211010-3RQOYD3EUJLFZP3PSH3PXHXKJE/ 首相官邸 https://twitter.com/kantei/status/1447056463814279169?t=L1YUI9TFWewuYXk6NgYeOA&s=19 首相官邸 https://m.facebook.com/story.php?story_fbid=pfbid02LCUxF5vfTqrJEammBaajp8isDxTdiBhVhZtpk8T97S61vt8tpY2cUidEVbQomRQ5l&id=314327765333656&locale=ja_JP
Written by CE7343FC743D4E7C1FAEA56CA165CB7D7D215C5D4998CE1CFF815B7E5688F59D
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1756537501161005135
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1756869396541444489
- noteId - 1756869396541444489
- participantId -
- noteAuthorParticipantId - CE7343FC743D4E7C1FAEA56CA165CB7D7D215C5D4998CE1CFF815B7E5688F59D Participant Details
- createdAtMillis - 1707705279845
- tweetId - 1756537501161005135
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 0
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 0
- misleadingMissingImportantContext - 1
- misleadingUnverifiedClaimAsFact - 0
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- この画像内で 岸田総理が行っているのは、デモンストレーションの視察です 健康な人で、実際の状況を再現した実演です 「総理は、宿泊療養等の説明を受けた後、治験概要の説明(治療薬、治験の概要説明及び投薬・健康観察等のデモンストレーション)を受けました」 視察する岸田総理7 首相官邸 https://www.kantei.go.jp/jp/100_kishida/actions/202110/10shisatsu.html 「塩野義製薬の治験デモンストレーションを見守る岸田首相」 首相、飲み薬の治験視察 https://www.sankei.com/article/20211010-3RQOYD3EUJLFZP3PSH3PXHXKJE/ 首相官邸 https://twitter.com/kantei/status/1447056463814279169?t=L1YUI9TFWewuYXk6NgYeOA&s=19 首相官邸 https://m.facebook.com/story.php?story_fbid=pfbid02LCUxF5vfTqrJEammBaajp8isDxTdiBhVhZtpk8T97S61vt8tpY2cUidEVbQomRQ5l&id=314327765333656&locale=ja_JP
Note Status History
createdAt | timestampMillisOfFirstNonNMRStatus | firstNonNMRStatus | timestampMillisOfCurrentStatus | currentStatus | timestampMillisOfLatestNonNMRStatus | mostRecentNonNMRStatus | participantId |
2024-02-12 02:34:39 UTC (1707705279845) |
2024-02-12 07:50:54 UTC (1707724254281) |
CURRENTLY_RATED_HELPFUL | 2024-02-13 04:55:47 UTC (1707800147240) |
CURRENTLY_RATED_HELPFUL | 2024-02-12 07:50:54 UTC (1707724254281) |
CURRENTLY_RATED_HELPFUL |
Note Ratings
rated at | rated by | |
2024-02-12 21:27:14 -0600 | Rating Details | |
2024-02-12 21:09:36 -0600 | Rating Details | |
2024-02-12 21:07:46 -0600 | Rating Details | |
2024-02-12 21:05:03 -0600 | Rating Details | |
2024-02-12 20:58:23 -0600 | Rating Details | |
2024-02-12 20:56:54 -0600 | Rating Details | |
2024-02-12 20:19:06 -0600 | Rating Details | |
2024-02-12 19:58:59 -0600 | Rating Details | |
2024-02-12 19:52:52 -0600 | Rating Details | |
2024-02-12 19:48:22 -0600 | Rating Details | |
2024-02-12 19:42:45 -0600 | Rating Details | |
2024-02-12 19:38:58 -0600 | Rating Details | |
2024-02-12 19:25:59 -0600 | Rating Details | |
2024-02-12 18:53:58 -0600 | Rating Details | |
2024-02-12 18:51:13 -0600 | Rating Details | |
2024-02-12 18:45:07 -0600 | Rating Details | |
2024-02-12 18:31:11 -0600 | Rating Details | |
2024-02-12 18:20:16 -0600 | Rating Details | |
2024-02-12 17:46:34 -0600 | Rating Details | |
2024-02-12 17:45:18 -0600 | Rating Details | |
2024-02-12 17:43:16 -0600 | Rating Details | |
2024-02-12 17:41:05 -0600 | Rating Details | |
2024-02-12 17:38:29 -0600 | Rating Details | |
2024-02-12 17:35:26 -0600 | Rating Details | |
2024-02-12 17:33:16 -0600 | Rating Details | |
2024-02-12 17:31:11 -0600 | Rating Details | |
2024-02-12 17:29:01 -0600 | Rating Details | |
2024-02-12 10:09:04 -0600 | Rating Details | |
2024-02-12 04:59:41 -0600 | Rating Details | |
2024-02-11 22:26:57 -0600 | Rating Details | |
2024-02-11 21:29:46 -0600 | Rating Details | |
2024-02-11 21:23:09 -0600 | Rating Details | |
2024-02-11 21:14:15 -0600 | Rating Details | |
2024-02-11 21:10:04 -0600 | Rating Details | |
2024-02-11 20:43:13 -0600 | Rating Details | |
2024-02-11 20:40:45 -0600 | Rating Details | |
2024-02-11 20:37:54 -0600 | Rating Details | |
2024-02-11 20:35:11 -0600 | Rating Details | |
2024-02-13 07:44:00 -0600 | Rating Details | |
2024-02-13 07:30:05 -0600 | Rating Details | |
2024-02-13 05:55:59 -0600 | Rating Details | |
2024-02-13 04:24:51 -0600 | Rating Details | |
2024-02-13 02:31:27 -0600 | Rating Details | |
2024-02-13 02:24:41 -0600 | Rating Details | |
2024-02-13 00:57:54 -0600 | Rating Details | |
2024-02-12 23:47:52 -0600 | Rating Details | |
2024-02-12 23:14:58 -0600 | Rating Details | |
2024-02-12 23:13:57 -0600 | Rating Details | |
2024-02-12 22:42:00 -0600 | Rating Details | |
2024-02-12 22:15:44 -0600 | Rating Details | |
2024-02-12 22:13:24 -0600 | Rating Details | |
2024-02-12 22:04:34 -0600 | Rating Details | |
2024-02-12 17:41:19 -0600 | Rating Details | |
2024-02-14 01:55:07 -0600 | Rating Details | |
2024-02-14 01:06:05 -0600 | Rating Details | |
2024-02-13 23:57:31 -0600 | Rating Details | |
2024-02-13 16:18:11 -0600 | Rating Details | |
2024-02-13 01:34:39 -0600 | Rating Details | |
2024-02-13 00:32:46 -0600 | Rating Details | |
2024-02-12 23:48:46 -0600 | Rating Details | |
2024-02-12 23:42:26 -0600 | Rating Details | |
2024-02-12 22:53:33 -0600 | Rating Details | |
2024-02-12 22:03:16 -0600 | Rating Details | |
2024-02-12 21:53:27 -0600 | Rating Details | |
2024-02-12 21:38:05 -0600 | Rating Details | |
2024-02-12 21:31:45 -0600 | Rating Details | |
2024-02-12 21:12:21 -0600 | Rating Details | |
2024-02-12 20:56:51 -0600 | Rating Details | |
2024-02-12 20:33:24 -0600 | Rating Details | |
2024-02-12 20:29:13 -0600 | Rating Details | |
2024-02-12 19:42:27 -0600 | Rating Details | |
2024-02-12 19:35:28 -0600 | Rating Details | |
2024-02-12 19:01:18 -0600 | Rating Details | |
2024-02-12 18:51:52 -0600 | Rating Details | |
2024-02-12 18:46:52 -0600 | Rating Details | |
2024-02-12 18:45:41 -0600 | Rating Details | |
2024-02-12 18:28:59 -0600 | Rating Details | |
2024-02-12 18:27:46 -0600 | Rating Details | |
2024-02-12 18:22:33 -0600 | Rating Details | |
2024-02-12 18:02:17 -0600 | Rating Details | |
2024-02-12 17:56:54 -0600 | Rating Details | |
2024-02-12 17:56:38 -0600 | Rating Details | |
2024-02-12 17:56:37 -0600 | Rating Details | |
2024-02-12 17:43:38 -0600 | Rating Details | |
2024-02-12 17:43:12 -0600 | Rating Details | |
2024-02-12 17:39:13 -0600 | Rating Details | |
2024-02-12 17:34:12 -0600 | Rating Details | |
2024-02-12 07:44:00 -0600 | Rating Details | |
2024-02-11 22:31:14 -0600 | Rating Details | |
2024-02-11 21:28:40 -0600 | Rating Details | |
2024-02-11 21:25:58 -0600 | Rating Details | |
2024-02-11 21:15:45 -0600 | Rating Details | |
2024-02-11 20:47:20 -0600 | Rating Details | |
2024-02-12 17:49:32 -0600 | Rating Details | |
2024-02-12 19:20:15 -0600 | Rating Details | |
2024-02-12 19:20:52 -0600 | Rating Details | |
2024-02-21 03:56:27 -0600 | Rating Details | |
2024-02-18 03:39:32 -0600 | Rating Details | |
2024-03-27 16:17:11 -0500 | Rating Details |